Abstract
FORMULATION AND EVALUATION OF FILM FORMING MICRO EMULION OF GARLIC EXTRACT CONTAINING POLYSULFANE DERIVATIVES TO POTENTIALLY INHIBIT THE SPREAD OF MELANOMA

Nitesh, K. Deekshitha*, F. M. Celvia, A. R. Shabaraya

ABSTRACT

Melanoma is a dangerous form of skin cancer caused by melanocytes, the cells that produce melanin. Although
less prevalent, it is extremely lethal due to its ability to metastasis to internal organs. Chemotherapy has long been
the primary treatment for metastatic melanoma, but it has serious adverse effects due to its non-selective action on
healthy cells. As a result, there is a rising interest in combining herbal treatments with innovative drug delivery
devices to improve treatment outcomes while reducing toxicity. Garlic (Allium sativum), which is widely used in
traditional medicine, has strong anti-cancer capabilities due to the presence of sulfur-containing chemicals such as
S-allyl cysteine, alliin, and ajoene. In multiple investigations, these bioactive’s have showed promise in
preventing melanoma cell proliferation and metastasis. As a result, the current study sought to create a stable and
effective film-forming microemulsion using garlic extract to treat melanoma. The formulation was tested for its
capacity to create films. The current study concludes that the herbal film-forming microemulsion provides a
natural, safe, and effective method against melanoma, offering a promising alternative to traditional chemotherapy
therapies.

Keywords: Melanoma, Garlic (Allium sativum), S-allyl cysteine(SAC), Alliin, Film forming microemulsion.


[Full Text Article]   [Download Certificate]

Indexing

Best Article Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: JULY ISSUE PUBLISHED

    JULY 2026 Issue has been successfully launched on 1 JULY 2026.

  • EJBPS: New Impact Factor 2026

    EJBPS Impact Factor has been Increased from  7.482 to 8.181 for Year 2026.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

Google Scholar Index Copernicus Indian Science Publications Urlich's Periodicals Directory, Proquest, UK (In Process) Research Bible, Fuchu, Tokyo. JAPAN UDLedge Science Citation Index International Society for Research activity (ISRA) Scientific Indexing Services (SIS) InfoBase Index (In Process) SJIF Impact Factor Scholar Article Impact Factor, SAIF Universal Impact Factor CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Global Impact Factor (GIF) (0.377) IP Indexing (IP Value 3.77) Web of Science Group (Under Process) Directory of Research Journals Indexing Scope Database Academia Academia Doi-Digital Online Identifier Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT